Suppr超能文献

台湾地区近期 HCV 感染的 HIV 阳性患者中病毒清除后的 HCV 再感染。

HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan.

机构信息

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Department of Internal Medicine, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan.

出版信息

Liver Int. 2019 Oct;39(10):1860-1867. doi: 10.1111/liv.14199. Epub 2019 Aug 5.

Abstract

BACKGROUND

Higher rates of hepatitis C virus (HCV) reinfection after viral clearance have been well described among HIV-positive men who have sex with men (MSM) in Europe. The epidemiology of HCV reinfection, however, has rarely been investigated among HIV-positive patients in Asia-Pacific region.

METHODS

We retrospectively identified HIV-positive patients with recent HCV infection who had cleared their primary infection, either spontaneously or via treatment, between January 2011 and May 2018. All included patients were observed until 31 March 2019. HCV reinfection was defined as recurrent HCV viraemia after achieving viral clearance with anti-HCV treatment or after spontaneous clearance.

RESULTS

During the study period, 219 HIV-positive patients (90.4% MSM) were diagnosed with recent HCV infection. Viral clearance with successful treatment was achieved in 108 patients (49.3%) and spontaneous clearance occurred in 20 (9.1%); of them, 18 (14.1%) acquired HCV reinfections, resulting in an incidence rate of 8.2 per 100 person-years of follow-up (95% CI 5.2-13.1). With the adjusted Cox proportional hazards model, we found a higher reinfection risk in patients with syphilis (adjusted hazard ratio 10.3, 95% CI 1.4-77.8, P = .023) compared to those without syphilis. HCV RNA testing, if performed only following syphilis and elevated aminotransferases, might miss 44.4% and 33.3% of HCV reinfections, respectively.

CONCLUSIONS

Similar to the findings in Europe, we observed a high incidence of HCV reinfection among HIV-positive Taiwanese with recent HCV infection, which was significantly associated with syphilis. To identify HCV reinfections, annual HCV RNA testing should be instituted instead of testing driven by symptoms, syphilis or elevated aminotransferases.

摘要

背景

在欧洲,HIV 阳性男男性接触者(MSM)中,清除病毒后丙型肝炎病毒(HCV)再感染率较高。然而,在亚太地区 HIV 阳性患者中,HCV 再感染的流行病学情况很少被研究。

方法

我们回顾性地确定了 2011 年 1 月至 2018 年 5 月期间清除原发性感染(自发或经治疗)的 HIV 阳性近期 HCV 感染者。所有纳入的患者均观察至 2019 年 3 月 31 日。HCV 再感染定义为抗 HCV 治疗后病毒清除或自发清除后 HCV 病毒血症再次出现。

结果

研究期间,219 名 HIV 阳性患者(90.4%为 MSM)被诊断为近期 HCV 感染。108 名患者(49.3%)经治疗实现病毒清除,20 名患者(9.1%)自发清除;其中 18 名(14.1%)发生 HCV 再感染,导致随访期间的发生率为 8.2/100 人年(95%CI 5.2-13.1)。经调整后的 Cox 比例风险模型发现,与无梅毒的患者相比,患有梅毒的患者再感染风险更高(调整后的风险比 10.3,95%CI 1.4-77.8,P=0.023)。如果仅在梅毒和转氨酶升高时进行 HCV RNA 检测,可能会分别漏诊 44.4%和 33.3%的 HCV 再感染。

结论

与欧洲的研究结果相似,我们观察到台湾 HIV 阳性近期 HCV 感染者的 HCV 再感染发生率较高,这与梅毒显著相关。为了识别 HCV 再感染,应每年进行 HCV RNA 检测,而不是根据症状、梅毒或转氨酶升高进行检测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验